Effect of a multimodal high intensity exercise intervention in cancer patients undergoing chemotherapy: randomised controlled trial

This study investigated the impact of a structured, multimodal exercise program on cancer patients who were undergoing chemotherapy. The intervention was designed as an *adjunct* to their conventional medical care, meaning it was an additional treatment, not a replacement.

The **intervention group** received a comprehensive exercise program that included:

**High-intensity cardiovascular training:** Exercises designed to elevate heart rate and improve endurance.

**Resistance training:** Exercises using weights or bodyweight to build muscular strength.

**Relaxation and body awareness training:** Techniques aimed at reducing stress, improving mental focus, and enhancing the connection between mind and body.

**Massage:** Therapeutic touch to aid muscle recovery and promote relaxation.

This program was supervised and conducted in a group setting for nine hours weekly over a period of six weeks.

The **comparator group** received only **conventional care**, which means they continued with their standard medical treatments (chemotherapy, doctor visits, etc.) but did not participate in the structured exercise program.

The researchers measured several **outcome measures** to assess the effects of the intervention:

**Fatigue:** A primary symptom often experienced by cancer patients, measured using a specific questionnaire.

**Physical capacity:** The ability to perform physical tasks, assessed through objective measures like maximum oxygen consumption and muscular strength.

**General wellbeing:** An overall sense of health and happiness.

**Physical activity:** The amount of exercise or movement individuals engaged in during their leisure time.

**Quality of life:** A broad measure encompassing physical, psychological, social, and functional aspects of life, as perceived by the individual.

The study included **269 patients with various types of cancer** who were undergoing either adjuvant chemotherapy (treatment given after primary treatment to kill remaining cancer cells) or treatment for advanced disease.

**Gender distribution:** 73 men and 196 women.

**Age:** The mean age was 47 years, with a range from 20 to 65 years.

**Diagnoses:** The participants represented 21 different cancer diagnoses, indicating a diverse patient population.

**Setting:** The study was conducted at two university hospitals located in Copenhagen, Denmark.

**Exclusion criteria:** Patients with brain or bone metastases were excluded from participating. This is important because these conditions can significantly impact a patient's ability to exercise safely and effectively, and their symptoms might overshadow the effects of the intervention.

**Completion rate:** 235 out of the 269 enrolled patients completed the full follow-up period, indicating a relatively high adherence rate for a study involving cancer patients undergoing treatment.

The researchers used a combination of widely recognized, validated questionnaires and objective physical tests to measure the various outcomes:

**Fatigue, Physical Functioning, Role Physical, Role Emotional, Global Health Status/Quality of Life:** These were primarily assessed using the **European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30)**. This is a cancer-specific, 30-item questionnaire designed to assess the quality of life of cancer patients. It includes functional scales (physical, role, emotional, cognitive, social functioning), symptom scales (fatigue, nausea and vomiting, pain, dyspnoea, insomnia, appetite loss, constipation, diarrhoea, financial difficulties), and a global health status/QoL scale. Scores are typically scaled from 0 to 100, with higher scores generally indicating better functioning or more severe symptoms, depending on the scale. For fatigue, a lower score would indicate less fatigue.

**Vitality, Mental Health:** These were measured using the **Medical Outcomes Study Short Form (MOS SF-36)**. This is a general health survey with 36 items, covering eight health domains: physical functioning, role limitations due to physical health, bodily pain, general health perceptions, vitality, social functioning, role limitations due to emotional problems, and mental health. Scores for each domain range from 0 to 100, with higher scores indicating better health or functioning.

**Leisure Time Physical Activity:** This was assessed using the **Leisure Time Physical Activity Questionnaire**. This type of questionnaire typically asks participants to recall the frequency, duration, and intensity of physical activities they engage in during their free time. While the specific scoring isn't detailed, it provides a self-reported measure of how active patients were outside of the study intervention.

**Muscular Strength:** This was objectively measured using **one repetition maximum (1RM)** tests. The 1RM is the maximum weight an individual can lift for a single repetition with proper form. The abstract specifically mentions "leg press" strength, indicating that lower body strength was a key focus. This is a direct, objective measure of strength, less prone to subjective bias than self-report.

**Maximum Oxygen Consumption (VO2max):** This is a gold standard objective measure of **aerobic capacity** or cardiovascular fitness. It represents the maximum rate of oxygen the body can use during intense exercise. VO2max is typically measured in litres per minute (l/min) or millilitres per kilogram of body weight per minute (ml/kg/min). A higher VO2max indicates better cardiovascular fitness. This is a highly reliable and objective physiological measure.

By using a combination of patient-reported outcomes (questionnaires) and objective physiological measures (1RM, VO2max), the researchers aimed to capture a comprehensive picture of the intervention's effects, balancing subjective experience with measurable physical changes.

This study employed a **Randomised Controlled Trial (RCT)** design, which is considered the gold standard for evaluating the effectiveness of interventions.

**Study Design:**

**Randomised Controlled Trial (RCT):** In an RCT, participants are randomly assigned to either an intervention group or a control group. This random assignment is crucial because it helps ensure that, on average, the two groups are similar in all characteristics (known and unknown) at the start of the study. This minimizes the risk that any observed differences in outcomes between the groups are due to pre-existing differences rather than the intervention itself.

**Setting:** The study was conducted in two university hospitals in Copenhagen, Denmark. This institutional setting suggests access to medical expertise and facilities, which is important for a study involving cancer patients.

**Participants:** 269 cancer patients were recruited. As mentioned, 235 completed the follow-up, indicating a 12.6% dropout rate.

**Randomisation:**

The abstract states it was a "Randomised controlled trial," which implies that participants were randomly assigned to either the exercise intervention group or the conventional care control group. However, the abstract does not provide specific details on *how* the randomisation was performed (e.g., method of randomisation like coin toss, computer-generated sequence, block randomisation, or stratification). While the fact of randomisation is a strength, the lack of detail means we cannot fully assess the robustness of the randomisation process. Proper randomisation is vital to ensure comparability between groups and reduce selection bias.

**Blinding:**

The abstract does not mention any blinding. For an exercise intervention, it is generally impossible to blind the participants (they know if they are exercising or not) or the instructors/therapists. It might have been possible to blind the outcome assessors for some objective measures (e.g., a technician performing a VO2max test who doesn't know the participant's group assignment), but this is not specified. The lack of blinding for participants and potentially for some assessors introduces a risk of **performance bias** (participants in the intervention group might try harder or report more positive outcomes due to their awareness of receiving an active treatment) and **detection bias** (assessors might consciously or unconsciously influence results if they know group assignments). This is a common limitation in exercise studies.

**Washout Periods:**

Washout periods are typically relevant in crossover designs, where participants switch between interventions. This study used a parallel-group design (each participant stays in one group for the duration), so washout periods were not applicable.

**Duration:**

The intervention lasted for **six weeks**. This is a relatively short duration for an exercise program, especially for chronic conditions like cancer. While it can show acute effects, it might not capture long-term sustainability or the full extent of benefits that could accrue over a longer period.

**Statistical Approach:**

For **continuous outcome measures** (like fatigue scores, VO2max, muscular strength), the **general linear model** was used. This statistical method is appropriate for analyzing the relationship between a continuous dependent variable and one or more independent variables (in this case, the intervention group vs. control group, adjusted for other factors). By adjusting for baseline scores, disease characteristics, and demographic covariates, the researchers aimed to isolate the effect of the exercise intervention more precisely, accounting for potential confounding factors.

For **categorical outcomes** (if any, though the main outcomes listed are continuous), the analysis of marginal homogeneity in contingency tables was performed. This method is used to compare paired categorical data, for example, to see if there's a change in the proportion of people in different categories over time within the same group or between groups.

**What this design can and cannot prove:**

**What it *can* prove:** As an RCT, this study has a strong capacity to establish a **causal link** between the multimodal exercise intervention and the observed improvements in fatigue, physical capacity, and certain aspects of wellbeing. The random assignment helps ensure that the intervention, rather than other factors, is responsible for the differences between groups. The use of objective measures like VO2max and 1RM further strengthens the causal inference for physical capacity.

**What it *cannot* prove:**

* **Long-term effects:** The 6-week duration means the study cannot determine if these benefits are sustained beyond the intervention period or if they continue to improve with longer-term exercise.

* **Generalizability to all cancer patients:** While diverse, the sample was from two specific hospitals and excluded patients with brain or bone metastases. The findings might not apply to patients with these specific conditions or those in different healthcare settings.

* **Mechanism of action:** While it shows *that* the intervention works, it doesn't deeply explore *how* it works at a physiological or psychological level (e.g., specific biological pathways, changes in immune function, detailed psychological processes).

* **Optimal dose/type of exercise:** The study tested a specific multimodal program (9 hours/week). It doesn't tell us if a different combination, intensity, or duration of exercise would be more or less effective.

* **Blinding limitations:**